Navigation Links
Plant hormone regulates nectar production
Date:3/29/2010

a, studied Brassica napus, a widespread and agriculturally important plant species. She found that when its flower tissues produced jasmonates during an early developmental stage, nectar production was immediately activated, regardless of whether the plant had been attacked by herbivores or not. "When we put caterpillars on the rapeseed leaves to elicit jasmonic acid production, the nectar secretion of the flowers was not affected," the researcher says. Spraying jasmonic acid on the green leaves also did not have an impact on the production of nectar in the flowers. However, when the scientist sprayed jasmonic acid directly on the flowers, nectar production increased dramatically. This clearly indicates that jasmonic acid has different functions in the different plant tissues: whereas the hormone activates defense mechanisms against herbivores in the leaves and the shoot of the plant, it regulates nectar production in the flower tissue.

The correlation between the production of jasmonic acid and nectar accumulation was demonstrated in experiments with an inhibitor: if the flowers had been treated with an inhibitor of jasmonic acid synthesis, the so-called phenidone, nectar production failed. If the substance was sprayed on young, still closed flower buds, however, their opening was inhibited, which confirms the importance of jasmonic acid also during the development of the flowers.

"The fact that jasmonic acid regulates so many functions, such as plant defense and pollination, is extremely interesting and raises new questions, especially concerning the evolution of these control mechanisms," says Martin Heil, the leader of the study. Wilhelm Boland, director at the Max Planck Institute in Jena, emphasizes: "The more we know about the hormonal effects on flower development and nectar production in agricultural crops like rapeseed, the better we can use this knowledge to ensure high yields." Even beekeepers could benefit from increased nectar
'/>"/>

Contact: Professor Martin Heil
mheil@ira.cinvestav.mx
52-462-623-9657
Max Planck Institute for Chemical Ecology
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Circadian clock controls plant growth hormone
2. Layered approach may yield stronger, more successful bone implants
3. Clearance of hepatitis C viral infection after liver transplantation
4. Device helps patients survive, regain function til transplant
5. How the plant immune system can drive the formation of new species
6. The American Society of Plant Biologists announces 2007 awards
7. UCR plant cell biologist to study how plant stem cells maintain and change their identity
8. A study proposes a new universal rule to explain the equilibrium of plant populations
9. A study proposes a new universal rule to explain the equilibrium of plant populations
10. Study shows vitamin C is essential for plant growth
11. Clever plants chat over their own network
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plant hormone regulates nectar production
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... Hole Research Center are analyzing the surprising results of the ... rainforest. , From January 2000 to July 2004, rainfall was ... of the Tapajós National Forest, in Brazil. A total of ... by 6' clear plastic panels suspended 3 to 12 feet ...
... Affymetrix Inc. (Nasdaq: AFFX - News) and Karolinska ... a strategic alliance designed to improve healthcare by ... tools for better diagnosis, prognosis, and treatment. , ... genetic analyses and measurement of gene expression in ...
... have discovered an important chemical in the brain's ... symptoms of opioid drugs like morphine and heroin. ... chemical--called a transporter--could relieve some of the early ... shaking, and jumpiness. Such drugs could become part ...
Cached Biology News:World's largest rainforest drying experiment completes first phase 2World's largest rainforest drying experiment completes first phase 3Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 2Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 3Key Trigger Of Opioid Withdrawal Symptoms Found 2
(Date:9/1/2015)... Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... and commercialization of targeted antiviral therapies, announced today that ... th Annual Global Investment Conference sponsored by ... 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide an ...
(Date:9/1/2015)... , ... September 01, 2015 ... ... launch of the new ImageXpress® Micro Confocal High-Content Imaging System. This transformative ... assays that use 3D cellular models such as spheroids, tissues, and organisms. ...
(Date:9/1/2015)... ... September 01, 2015 , ... AxioMx Inc. , a ... Institutes of Health (NIH) has awarded the company a Phase I Small Business ... Institute of Diabetes and Digestive and Kidney Diseases. AxioMx will use this award ...
(Date:9/1/2015)... The Dohmen Company today announced the ... as Chief Science Officer (CSO) of Dohmen Life ... Dr. Floyd will lead Dohmen,s growing regulatory consulting ... and post approval outsourced services in quality, regulatory, ... Floyd brings decades of experience leading global regulatory ...
Breaking Biology Technology:ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 2ImageXpress Micro Confocal High-Content Imaging System Expands the Boundaries of Research 3AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 2Dohmen Life Science Services Appoints Eric Floyd, Ph.D. as Chief Science Officer 3
... Brain Metastases, PALO ALTO, Calif., Sept. 2 ... radiosurgery treatments for,multiple brain metastases using new RapidArc ... ). The MIMA Cancer Center in Melbourne,Florida and ... able to treat brain metastases more quickly and ...
... BMRN ) today announced that Jean-Jacques,Bienaime, Chief Executive ... 3rd Annual Citi Biotech Day in New York City ... Interested parties may access a live audio webcast of ... website, http://www.BMRN.com .,A replay of the call will ...
... development milestone payment to InterMune - ... to lead ITMN-191 program in Phase 2 -, BRISBANE, ... announced that InterMune has earned a $15 million,development milestone under ... NS3 protease inhibitor compound ITMN-191,(referred to as R7227 at Roche), ...
Cached Biology Technology:Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 4BioMarin to Present at the Citi Biotech Day 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4